Cargando…
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program
In 1994, a pilot program of cervical cancer screening was introduced in the Alsace region, France. Women aged 25–65 years were proposed to have one Pap smear every 3 years. The objective was to assess cervical morbidity in Alsace before the human papillomavirus vaccinated population reaches the age...
Autores principales: | Baldauf, Jean-Jacques, Fender, Muriel, Bergeron, Christine, Marrer, Emilie, Velten, Michel, Pradat, Pierre, Arbyn, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296848/ https://www.ncbi.nlm.nih.gov/pubmed/29135538 http://dx.doi.org/10.1097/CEJ.0000000000000415 |
Ejemplares similares
-
Updated evidence-based recommendations for cervical cancer screening in France
por: Hamers, Françoise F., et al.
Publicado: (2021) -
L'Alsace
por: Nicolas, Michel -
The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer
por: Song, Jiheon, et al.
Publicado: (2020) -
Advances in immunotherapy for cervical cancer
por: Grau-Bejar, Juan Francisco, et al.
Publicado: (2023) -
Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France
por: Boyer, Pierre H., et al.
Publicado: (2020)